JNJ: Focused on high-growth MedTech markets, innovation, and portfolio shifts, strong growth is projected
MedTech is on track for high-end growth, driven by a focused shift into cardiovascular, surgery, and vision, with robust innovation and a new operating model. Despite competitive and geopolitical headwinds, confidence remains high for 2026 and beyond, with major contributions expected from OTTAVA a…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.